Newark and Bassetlaw are free of Hep C

Hepatitis C (hep C) is one of the most common blood borne viruses in the country. If left untreated, the Hepatitis C virus can cause serious and potentially life-threatening damage to the liver.

Micro-elimination is a new way of tackling hepatitis C in local areas. It uses a series of targets to make sure that people are being diagnosed and getting the treatment they need quickly and easily.

When we say an area has micro-eliminated hepatitis C, that means it has reached these targets:

• 100% of people using the service have been offered a hepatitis C test.
• 90% of these people have then been tested.
• 75% of people who were diagnosed with hepatitis C have started treatment.

NHS England set these micro-elimination targets, to eliminate hepatitis C as a major health concern by 2025.

We have achieved micro-elimination!

Our team have worked tirelessly to achieve micro-elimination, working with our NHS partners (of South Yorkshire and Nottinghamshire Hepatitis C Operational Delivery Networks), The Hep C Trust, and Gilead Sciences to reach the following targets in our Nottinghamshire Newark/Bassetlaw locality:

• 100% of people using the service have been offered a hepatitis C test.
• 98% of people with a history of injecting have been tested.
• 90% with current risk factors have been tested within the last 12 months
• 90% of people who were diagnosed with hepatitis C have started successfully linked into treatment

This is a fantastic achievement and has been an excellent example of collaborative working.

We would like to congratulate and say a huge thank you to the team in our Nottinghamshire Newark and Bassetlaw locality involved. All of whom have worked so incredibly hard to steer us to this amazing milestone. The absolute dedication by this service locality has made such an enormous difference to lives of many individuals accessing the service.